News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
371,473 Results
Type
Article (27649)
Company Profile (62)
Press Release (343762)
Section
Business (103644)
Career Advice (1358)
Deals (18572)
Drug Delivery (63)
Drug Development (52039)
Employer Resources (96)
FDA (10482)
Job Trends (8811)
News (188661)
Policy (19836)
Tag
Academia (2030)
Alliances (26558)
Alzheimer's disease (1089)
Approvals (10483)
Artificial intelligence (81)
Bankruptcy (208)
Best Places to Work (7198)
Breast cancer (122)
Cancer (874)
Cardiovascular disease (84)
Career advice (1158)
Cell therapy (170)
Clinical research (41454)
Collaboration (306)
Compensation (90)
COVID-19 (1535)
Data (1030)
Diabetes (130)
Diagnostics (4640)
Drug pricing (67)
Earnings (41815)
Employer resources (80)
Events (48700)
Executive appointments (192)
FDA (10950)
Funding (239)
Gene therapy (150)
GLP-1 (421)
Government (2975)
Healthcare (11408)
Infectious disease (1599)
Inflammatory bowel disease (62)
Interviews (203)
IPO (8160)
Job creations (1886)
Job search strategy (1036)
Layoffs (209)
Legal (4584)
Lung cancer (135)
Lymphoma (67)
Manufacturing (103)
Medical device (7601)
Medtech (7602)
Mergers & acquisitions (10473)
Metabolic disorders (330)
Neuroscience (1307)
NextGen Class of 2024 (3813)
Non-profit (2879)
Northern California (1023)
Obesity (171)
Opinion (126)
Parkinson's disease (62)
Patents (65)
People (28057)
Phase I (12005)
Phase II (18176)
Phase III (14424)
Pipeline (382)
Postmarket research (1831)
Preclinical (5742)
Radiopharmaceuticals (144)
Rare diseases (172)
Real estate (3198)
Regulatory (13243)
Research institute (1601)
Resumes & cover letters (183)
Southern California (852)
Startups (1864)
United States (8671)
Vaccines (304)
Weight loss (114)
Date
Last 7 days (87)
Last 30 days (949)
Last 365 days (20502)
2025 (52)
2024 (20848)
2023 (23703)
2022 (30532)
2021 (32753)
2020 (31490)
2019 (27138)
2018 (20855)
2017 (19199)
2016 (18465)
2015 (21417)
2014 (15638)
2013 (12733)
2012 (13531)
2011 (13930)
2010 (12516)
Location
Africa (453)
Asia (20399)
Australia (3862)
California (2197)
Canada (827)
China (155)
Colorado (108)
Connecticut (92)
Europe (48453)
Florida (298)
Georgia (77)
Illinois (216)
Indiana (130)
Kansas (65)
Maryland (330)
Massachusetts (1495)
Michigan (105)
Minnesota (140)
New Jersey (734)
New York (701)
North Carolina (448)
Northern California (1023)
Ohio (94)
Pennsylvania (505)
South America (633)
Southern California (852)
Texas (351)
Utah (70)
Washington State (257)
371,473 Results for "charles river laboratories pathology associates pai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories to Present at Evercore ISI Investor Conference
December 2, 2024
·
1 min read
Press Releases
Charles River Laboratories to Present at UBS and Jefferies Conferences
November 11, 2024
·
1 min read
BioCapital
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
New turnkey research facility will provide AAALAC-accredited flexible vivarium space for Massachusetts biopharmaceutical hub Charles River Laboratories International, Inc. has announced the opening of a new Charles River Accelerator and Development Lab facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub.
June 6, 2024
·
3 min read
Press Releases
Charles River Laboratories Announces Third-Quarter 2024 Results
November 6, 2024
·
20 min read
Business
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI.
April 11, 2024
·
3 min read
Business
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.
June 25, 2024
·
4 min read
Business
Charles River Laboratories Announces First-Quarter 2024 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023.
May 9, 2024
·
29 min read
Business
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its Virtual Control Groups (VCG) initiative with Sanofi.
June 4, 2024
·
3 min read
Genetown
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-leading team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting.
April 1, 2024
·
5 min read
BioCapital
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Laboratories International, Inc. announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023.
March 27, 2024
·
5 min read
1 of 37,148
Next
